Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐Analysis

ABSTRACT Objective This meta‐analysis aimed to evaluate the comparative diagnostic performance of amyloid‐β positron emission tomography (Aβ PET) and magnetic resonance imaging (MRI) in diagnosing Alzheimer's disease (AD). Methods An extensive search was conducted in the PubMed and Embase datab...

Full description

Saved in:
Bibliographic Details
Main Authors: Fang Li, Jiang Cheng, Kaihui Jin, Li Zhao, Junyong Li, Jia Wu, Xiaolu Ren
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:Brain and Behavior
Subjects:
Online Access:https://doi.org/10.1002/brb3.70111
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850201374419058688
author Fang Li
Jiang Cheng
Kaihui Jin
Li Zhao
Junyong Li
Jia Wu
Xiaolu Ren
author_facet Fang Li
Jiang Cheng
Kaihui Jin
Li Zhao
Junyong Li
Jia Wu
Xiaolu Ren
author_sort Fang Li
collection DOAJ
description ABSTRACT Objective This meta‐analysis aimed to evaluate the comparative diagnostic performance of amyloid‐β positron emission tomography (Aβ PET) and magnetic resonance imaging (MRI) in diagnosing Alzheimer's disease (AD). Methods An extensive search was conducted in the PubMed and Embase databases to identify available publications up to December 2023. Head‐to‐head comparative studies were included if they evaluated the diagnostic performance of Aβ PET and MRI in diagnosing Alzheimer's disease. Sensitivity and specificity were assessed using the DerSimonian and Laird method, followed by transformation via the Freeman–Tukey double inverse sine transformation. Results Six articles involving 560 patients were included in the meta‐analysis. When distinguishing AD from mild cognitive impairment (MCI), both methods showed comparable sensitivity (Aβ PET: 0.71, MRI: 0.62) and specificity (Aβ PET: 0.68, MRI: 0.69), with no statistically significant differences observed (p = 0.34 and 0.99). When identifying AD from normal cognitive control (NC), both Aβ PET and MRI showed similar results, with comparable sensitivity (Aβ PET: 0.93, MRI: 0.85) and specificity (Aβ PET: 0.95, MRI: 0.82), without significant differences (p = 0.38 and 0.19). Similarly, in detecting MCI from NC, both Aβ PET and MRI demonstrated similar sensitivity (Aβ PET: 0.69, MRI: 0.64) and specificity (Aβ PET: 0.75, MRI: 0.76) without significant differences (p = 0.40 and 0.94). However, 18F‐FMM seems to have a higher specificity compared to MRI when distinguishing AD from MCI (P = 0.03) and AD from NC (p = 0.04). Conclusions Our meta‐analysis indicates that Aβ PET demonstrates similar sensitivity and specificity to MRI in diagnosing Alzheimer's disease. However, the limited number of studies may impact the evidence of the current study; further larger sample prospective research is required to confirm these findings.
format Article
id doaj-art-ef08d294ba7c4f579c5116a7f1962788
institution OA Journals
issn 2162-3279
language English
publishDate 2024-10-01
publisher Wiley
record_format Article
series Brain and Behavior
spelling doaj-art-ef08d294ba7c4f579c5116a7f19627882025-08-20T02:12:02ZengWileyBrain and Behavior2162-32792024-10-011410n/an/a10.1002/brb3.70111Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐AnalysisFang Li0Jiang Cheng1Kaihui Jin2Li Zhao3Junyong Li4Jia Wu5Xiaolu Ren6Department of Neurology General Hospital of Ningxia Medical University Yinchuan ChinaDepartment of Neurology General Hospital of Ningxia Medical University Yinchuan ChinaDepartment of Neurology General Hospital of Ningxia Medical University Yinchuan ChinaDepartment of Neurology General Hospital of Ningxia Medical University Yinchuan ChinaDepartment of Neurology General Hospital of Ningxia Medical University Yinchuan ChinaDepartment of Neurology General Hospital of Ningxia Medical University Yinchuan ChinaDepartment of Radiology General Hospital of Ningxia Medical University Yinchuan ChinaABSTRACT Objective This meta‐analysis aimed to evaluate the comparative diagnostic performance of amyloid‐β positron emission tomography (Aβ PET) and magnetic resonance imaging (MRI) in diagnosing Alzheimer's disease (AD). Methods An extensive search was conducted in the PubMed and Embase databases to identify available publications up to December 2023. Head‐to‐head comparative studies were included if they evaluated the diagnostic performance of Aβ PET and MRI in diagnosing Alzheimer's disease. Sensitivity and specificity were assessed using the DerSimonian and Laird method, followed by transformation via the Freeman–Tukey double inverse sine transformation. Results Six articles involving 560 patients were included in the meta‐analysis. When distinguishing AD from mild cognitive impairment (MCI), both methods showed comparable sensitivity (Aβ PET: 0.71, MRI: 0.62) and specificity (Aβ PET: 0.68, MRI: 0.69), with no statistically significant differences observed (p = 0.34 and 0.99). When identifying AD from normal cognitive control (NC), both Aβ PET and MRI showed similar results, with comparable sensitivity (Aβ PET: 0.93, MRI: 0.85) and specificity (Aβ PET: 0.95, MRI: 0.82), without significant differences (p = 0.38 and 0.19). Similarly, in detecting MCI from NC, both Aβ PET and MRI demonstrated similar sensitivity (Aβ PET: 0.69, MRI: 0.64) and specificity (Aβ PET: 0.75, MRI: 0.76) without significant differences (p = 0.40 and 0.94). However, 18F‐FMM seems to have a higher specificity compared to MRI when distinguishing AD from MCI (P = 0.03) and AD from NC (p = 0.04). Conclusions Our meta‐analysis indicates that Aβ PET demonstrates similar sensitivity and specificity to MRI in diagnosing Alzheimer's disease. However, the limited number of studies may impact the evidence of the current study; further larger sample prospective research is required to confirm these findings.https://doi.org/10.1002/brb3.70111Alzheimer's diseaseamyloid‐βmagnetic resonance imagingpositron emission tomography
spellingShingle Fang Li
Jiang Cheng
Kaihui Jin
Li Zhao
Junyong Li
Jia Wu
Xiaolu Ren
Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐Analysis
Brain and Behavior
Alzheimer's disease
amyloid‐β
magnetic resonance imaging
positron emission tomography
title Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐Analysis
title_full Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐Analysis
title_fullStr Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐Analysis
title_full_unstemmed Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐Analysis
title_short Comparative Diagnostic Performance of Amyloid‐β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head‐to‐Head Meta‐Analysis
title_sort comparative diagnostic performance of amyloid β positron emission tomography and magnetic resonance imaging in alzheimer s disease a head to head meta analysis
topic Alzheimer's disease
amyloid‐β
magnetic resonance imaging
positron emission tomography
url https://doi.org/10.1002/brb3.70111
work_keys_str_mv AT fangli comparativediagnosticperformanceofamyloidbpositronemissiontomographyandmagneticresonanceimaginginalzheimersdiseaseaheadtoheadmetaanalysis
AT jiangcheng comparativediagnosticperformanceofamyloidbpositronemissiontomographyandmagneticresonanceimaginginalzheimersdiseaseaheadtoheadmetaanalysis
AT kaihuijin comparativediagnosticperformanceofamyloidbpositronemissiontomographyandmagneticresonanceimaginginalzheimersdiseaseaheadtoheadmetaanalysis
AT lizhao comparativediagnosticperformanceofamyloidbpositronemissiontomographyandmagneticresonanceimaginginalzheimersdiseaseaheadtoheadmetaanalysis
AT junyongli comparativediagnosticperformanceofamyloidbpositronemissiontomographyandmagneticresonanceimaginginalzheimersdiseaseaheadtoheadmetaanalysis
AT jiawu comparativediagnosticperformanceofamyloidbpositronemissiontomographyandmagneticresonanceimaginginalzheimersdiseaseaheadtoheadmetaanalysis
AT xiaoluren comparativediagnosticperformanceofamyloidbpositronemissiontomographyandmagneticresonanceimaginginalzheimersdiseaseaheadtoheadmetaanalysis